chartexchange

Zevra Therapeutics Reports Q3 2026 Earnings: Revenue Surges to $37.8 Million, EPS of $0. ...

GuruFocus | Nov 3, 2026 4:37 PM EST

Revenue of $37.8 Million Edges Past the $37.08 Million Consensus, Aided by Miplyffa Sales and Expanded Access Program Reimbursements Related Stocks: ZVRA ,

Read original article